Analyze Diet

Prolyl-Hydroxyproline Promotes Structural Matrix Organization in 3D Equine Tendon Proper and Peritenon Post-Injury Model.

Abstract: Tendinopathy of the superficial digital flexor tendon affects horse health and performance, with slow healing and high re-injury rates due to the formation of mechanically weaker scar tissue. Tendons are rich in Type I collagen and may benefit from supplementation with collagen-derived dipeptide prolyl hydroxyproline (H-Pro-Hyp-OH) which improves collagen regeneration and reduces scarring in murine injury models. However, its effects on equine tenocytes in the tendon proper (TP) and peritenon (PERI) under stress are unknown. Three-dimensional fibrin-based TP and PERI constructs were used to evaluate the effects of H-Pro-Hyp-OH within TP and PERI niches under control conditions and simulated post-injury environments. Constructs were treated with H-Pro-Hyp-OH alone or in combination with inflammatory (Interleukin-1 beta, IL-1β) or glucocorticoid (dexamethasone, DEX) stimuli. Gene expression was assessed by RT-qPCR, collagen content was quantified using a hydroxyproline assay, and tendon ultrastructure was evaluated using second harmonic generation imaging. Under control conditions, H-Pro-Hyp-OH enhanced alignment in TP. Under inflammatory and DEX stress, H-Pro-Hyp-OH did not reverse stress-induced transcriptional shifts or restore collagen content. However, H-Pro-Hyp-OH treatment improved collagen fibril organization and alignment, with structural rescue seen in PERI constructs. In stressful conditions induced by IL-1β or DEX, structural improvements did not always correspond with biochemical measurements of collagen, suggesting that H-Pro-Hyp-OH promotes matrix organization rather than bulk collagen accumulation in adverse post-injury environments. The responsiveness of PERI cells highlights the importance of targeting the extrinsic repair niche to promote functional tendon repair and limit fibrotic scarring.
Publication Date: 2026-09-21 PubMed ID: 42765573PubMed Central: PMC13591663DOI: 10.1002/jor.70284Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study investigates the effect of the collagen-derived dipeptide prolyl hydroxyproline (H-Pro-Hyp-OH) on tendon cells from different regions of equine tendons, specifically the tendon proper (TP) and peritenon (PERI), under normal and simulated post-injury conditions.
  • The research aims to understand how H-Pro-Hyp-OH could improve structural matrix organization and potentially aid tendon healing after injury in horses.

Background and Purpose

  • Tendinopathy, particularly of the superficial digital flexor tendon in horses, causes significant health and performance issues due to slow healing and high rates of re-injury.
  • The healing process often leads to the formation of scar tissue that is mechanically weaker than healthy tendon tissue.
  • Type I collagen is a major component of tendons and critical for their mechanical strength.
  • Previous research in mouse models suggests that the dipeptide prolyl hydroxyproline (H-Pro-Hyp-OH) can enhance collagen regeneration and reduce scar formation post-injury.
  • This study aims to explore whether H-Pro-Hyp-OH has similar benefits on horse tendon cells, focusing on two distinct niches: the tendon proper (TP) and the peritenon (PERI), under both normal and simulated injury (inflammatory or glucocorticoid) conditions.

Methods

  • Three-dimensional fibrin-based constructs mimicking the tendon proper (TP) and peritenon (PERI) environments were created to cultivate equine tenocytes.
  • The constructs were treated under various conditions:
    • Control (normal conditions)
    • H-Pro-Hyp-OH supplementation alone
    • H-Pro-Hyp-OH combined with inflammatory stimulus (Interleukin-1 beta, IL-1β)
    • H-Pro-Hyp-OH combined with glucocorticoid stimulus (dexamethasone, DEX)
  • Several experimental techniques were employed to analyze outcomes:
    • RT-qPCR to assess gene expression changes, indicating cellular responses at the transcriptional level.
    • Hydroxyproline assay to quantify collagen content in the tendon constructs.
    • Second harmonic generation imaging to evaluate collagen fibril structure and alignment—this noninvasive imaging technique highlights collagen’s ultrastructural organization.

Key Findings

  • Under normal control conditions:
    • H-Pro-Hyp-OH improved collagen fibril alignment in the tendon proper (TP) constructs, indicating enhanced matrix organization.
  • Under simulated post-injury conditions (with IL-1β inflammatory stimulus or DEX glucocorticoid stress):
    • H-Pro-Hyp-OH did not reverse gene expression changes or restore collagen content reduced by stress, showing limited effects on bulk biochemical collagen levels or transcriptional shifts.
    • Despite this, H-Pro-Hyp-OH improved collagen fibril organization and alignment, particularly in the peritenon (PERI) constructs, demonstrating a rescue effect on tendon ultrastructure.
  • The dissociation between biochemical collagen quantity and improved collagen microstructure suggests that H-Pro-Hyp-OH helps organize existing collagen rather than increasing its production during stress.
  • The peritenon (extrinsic) cells were more responsive to the treatment than the tendon proper cells, highlighting the role of the extrinsic niche in promoting functional tendon repair.

Implications and Significance

  • This study highlights the potential therapeutic role of prolyl hydroxyproline in improving collagen matrix organization in equine tendons, especially after injury.
  • Improved collagen alignment and ultrastructural organization could enhance the mechanical properties of the tendon matrix, potentially reducing scar formation and re-injury risks.
  • Targeting the peritenon, often considered the extrinsic repair niche, may provide a novel strategy to promote better structural repair of tendons.
  • Since H-Pro-Hyp-OH did not increase collagen quantity under stress, combining it with other treatments might be necessary to fully restore tendon health post-injury.
  • Overall, this research adds to the growing evidence that matrix organization, not just collagen amount, is critical in tendon healing and function.

Cite This Article

APA
Wong AO, Mienaltowski MJ. (2026). Prolyl-Hydroxyproline Promotes Structural Matrix Organization in 3D Equine Tendon Proper and Peritenon Post-Injury Model. J Orthop Res, 44(9), e70284. https://doi.org/10.1002/jor.70284

Publication

ISSN: 1554-527X
NlmUniqueID: 8404726
Country: United States
Language: English
Volume: 44
Issue: 9
Pages: e70284
PII: e70284

Researcher Affiliations

Wong, Angelique O
  • Department of Animal Science, College of Agricultural & Environmental Sciences, University of California Davis, Davis, California, USA.
Mienaltowski, Michael J
  • Department of Animal Science, College of Agricultural & Environmental Sciences, University of California Davis, Davis, California, USA.

MeSH Terms

  • Animals
  • Horses
  • Tendon Injuries / drug therapy
  • Tendons / drug effects
  • Tendons / ultrastructure
  • Dipeptides / pharmacology
  • Dipeptides / therapeutic use
  • Tenocytes / drug effects

Grant Funding

  • 22A / UC Davis Center for Equine Health
  • Division of Agriculture and Natural Resources, University of California
  • College of Agricultural and Environmental Sciences, University of California, Davis

Conflict of Interest Statement

The authors declare no conflicts of interest.

References

This article includes 57 references
  1. Ikeda Y, Ishihara A, Nakajima M, Yamada K. Risk Factors for Superficial Digital Flexor Tendinopathy in Thoroughbred Racing Horses in Japan. Journal of Equine Science 30, no. 4 (2019): 93–98.
    pmc: PMC6920055pubmed: 31871411
  2. Kasashima Y, Takahashi T, Smith R K W. Prevalence of Superficial Digital Flexor Tendonitis and Suspensory Desmitis in Japanese Thoroughbred Flat Racehorses in 1999. Equine Veterinary Journal 36, no. 4 (2004): 346–350.
    pubmed: 15163043
  3. Tipton T E, Ray C S, Hand D R. Superficial Digital Flexor Tendonitis in Cutting Horses: 19 Cases (2007–2011). Journal of the American Veterinary Medical Association 243, no. 8 (2013): 1162–1165.
    pubmed: 24094264
  4. Thorpe C T, Clegg P D, Birch H L. A Review of Tendon Injury: Why Is the Equine Superficial Digital Flexor Tendon Most at Risk?. Equine Veterinary Journal 42, no. 2 (2010): 174–180.
    pubmed: 20156256
  5. Ülke Ç G, Deniz S I, Nureddin Ç. Evaluation of Return Rates to Races in Racehorses After Tendon Injuries: Lesion‐Related Parameters. Journal of Equine Veterinary Science 87 (2020): 102931.
    pubmed: 32172919
  6. Williams R B, Harkins L S, Hammond C J, Wood J L N. Racehorse Injuries, Clinical Problems and Fatalities Recorded on British Racecourses From Flat Racing and National Hunt Racing during 1996, 1997, and 1998. Equine Veterinary Journal 33, no. 5 (2001): 478–486.
    pubmed: 11558743
  7. Alexander R M, Bennet‐Clark H C. Storage of Elastic Strain Energy in Muscle and Other Tissues. Nature 265, no. 5590 (1977): 114–117.
    pubmed: 834252
  8. Birch H L. Tendon Matrix Composition and Turnover in Relation to Functional Requirements. International Journal of Experimental Pathology 88, no. 4 (2007): 241–248.
    pmc: PMC2517317pubmed: 17696905
  9. Leach D H, Ormrod K, Clayton H M. Standardised Terminology for the Description and Analysis of Equine Locomotion. Equine Veterinary Journal 16, no. 6 (1984): 522–528.
    pubmed: 6519042
  10. Clegg P D. Musculoskeletal Disease and Injury, Now and in the Future. Part 2: Tendon and Ligament Injuries. Equine Veterinary Journal 44, no. 3 (2012): 371–375.
    pubmed: 22486548
  11. Dyson S J. Medical Management of Superficial Digital Flexor Tendonitis: A Comparative Study in 219 Horses (1992–2000). Equine Veterinary Journal 36, no. 5 (2004): 415–419.
    pubmed: 15253082
  12. Hung L K, Fu S C, Lee Y W, Mok T Y, Chan K M. Local Vitamin‐C Injection Reduced Tendon Adhesion in a Chicken Model of Flexor Digitorum Profundus Tendon Injury. Journal of Bone and Joint Surgery 95, no. 7 (2013): e41.
    pubmed: 23553304
  13. Howell K, Chien C, Bell R. Novel Model of Tendon Regeneration Reveals Distinct Cell Mechanisms Underlying Regenerative and Fibrotic Tendon Healing. Scientific Reports 7, no. 1 (2017): 45238.
    pmc: PMC5362908pubmed: 28332620
  14. López De Padilla C M, Coenen M J, Tovar A, De la Vega R E, Evans C H, Müller S A. Picrosirius Red Staining: Revisiting Its Application to the Qualitative and Quantitative Assessment of Collagen Type I and Type III in Tendon. Journal of Histochemistry & Cytochemistry 69, no. 10 (2021): 633–643.
    pmc: PMC8504258pubmed: 34549650
  15. Mienaltowski M J, Callahan M, Gonzales N L, Wong A. Examining the Potential of Vitamin C Supplementation in Tissue‐Engineered Equine Superficial Digital Flexor Tendon Constructs. International Journal of Molecular Sciences 24, no. 23 (2023): 17098.
    pmc: PMC10707379pubmed: 38069418
  16. Pechanec M. Y., Mienaltowski M. J.. Decoding the Transcriptomic Expression and Genomic Methylation Patterns in the Tendon Proper and Its Peritenon Region in the Aging Horse. BMC Research Notes 16, no. 1 (2023): 267.
    pmc: PMC10566085pubmed: 37821884
  17. Ramachandran G. N., Kartha G.. Structure of Collagen. Nature 176, no. 4482 (1955): 593–595.
    pubmed: 13265783
  18. Mienaltowski M. J., Birk D. E.. Structure, Physiology, and Biochemistry of Collagens. Advances in Experimental Medicine and Biology 802 (2014): 5–29.
    pubmed: 24443018
  19. Mienaltowski M. J., Adams S. M., Birk D. E.. Regional Differences in Stem Cell/Progenitor Cell Populations From the Mouse Achilles Tendon. Tissue Engineering. Part A 19, no. 1–2 (2013): 199–210.
    pmc: PMC3530943pubmed: 22871316
  20. Mienaltowski M. J., Adams S. M., Birk D. E.. Tendon Proper‐ and Peritenon‐Derived Progenitor Cells Have Unique Tenogenic Properties. Stem Cell Research & Therapy 5, no. 4 (2014): 86.
    pmc: PMC4230637pubmed: 25005797
  21. Dyment N. A., Liu C. F., Kazemi N.. The Paratenon Contributes to Scleraxis‐Expressing Cells during Patellar Tendon Healing. PLoS One 8, no. 3 (2013): e59944.
    pmc: PMC3608582pubmed: 23555841
  22. Millar N. L., Silbernagel K. G., Thorborg K.. Tendinopathy. Nature Reviews Disease Primers 7, no. 1 (2021): 1.
    pubmed: 33414454
  23. Del Buono A., Oliva F., Osti L., Maffulli N.. Metalloproteases and Tendinopathy. Muscles, Ligaments and Tendons Journal 3, no. 1 (2013): 51–57.
    pmc: PMC3676164pubmed: 23885345
  24. Dakin S. G., Buckley C. D., Al‐Mossawi M. H.. Persistent Stromal Fibroblast Activation Is Present in Chronic Tendinopathy. Arthritis Research & Therapy 19, no. 1 (2017): 16.
    pmc: PMC5264298pubmed: 28122639
  25. Zhang K., Asai S., Yu B., Enomoto‐Iwamoto M.. IL‐1β Irreversibly Inhibits Tenogenic Differentiation and Alters Metabolism In Injured Tendon‐Derived Progenitor Cells In Vitro. Biochemical and Biophysical Research Communications 463, no. 4 (2015): 667–672.
    pmc: PMC4496264pubmed: 26051275
  26. Thampatty B. P., Li H., Im H. J., Wang J. H. C.. EP4 Receptor Regulates Collagen Type‐I, MMP‐1, and MMP‐3 Gene Expression in Human Tendon Fibroblasts in Response to IL‐1β Treatment. Gene 386, no. 1–2 (2007): 154–161.
    pmc: PMC1839868pubmed: 17046175
  27. Baugé C., Leclercq S., Conrozier T., Boumediene K.. TOL19‐001 Reduces Inflammation and MMP Expression in Monolayer Cultures of Tendon Cells. BMC Complementary and Alternative Medicine 15 (2015): 217.
    pmc: PMC4495633pubmed: 26156631
  28. Spang C., Chen J., Backman L. J.. The Tenocyte Phenotype of Human Primary Tendon Cells In Vitro Is Reduced by Glucocorticoids. BMC Musculoskeletal Disorders 17 (2016): 467.
    pmc: PMC5105245pubmed: 27832770
  29. Haines J. F.. Bilateral Rupture of the Achilles Tendon in Patients on Steroid Therapy. Annals of the Rheumatic Diseases 42, no. 6 (1983): 652–654.
    pmc: PMC1001322pubmed: 6651370
  30. Kotnis R. A., Halstead J. C., Hormbrey P. J.. Atraumatic Bilateral Achilles Tendon Rupture: An Association of Systemic Steroid Treatment. Emergency Medicine Journal 16, no. 5 (1999): 378–379.
    pmc: PMC1347070pubmed: 10505929
  31. Baruah D. R.. Bilateral Spontaneous Rupture of the Achilles Tendons in a Patient on Long‐Term Systemic Steroid Therapy. British Journal of Sports Medicine 18, no. 2 (1984): 128–129.
    pmc: PMC1859205pubmed: 6466930
  32. Zhang J., Keenan C., Wang J. H. C.. The Effects of Dexamethasone on Human Patellar Tendon Stem Cells: Implications for Dexamethasone Treatment of Tendon Injury. Journal of Orthopaedic Research 31, no. 1 (2013): 105–110.
    pmc: PMC3498577pubmed: 22886634
  33. Haratake A., Watase D., Fujita T., Setoguchi S., Matsunaga K., Takata J.. Effects of Oral Administration of Collagen Peptides on Skin Collagen Content and Its Underlying Mechanism using a Newly Developed Low Collagen Skin Mice Model. Journal of Functional Foods 16 (2015): 174–182.
  34. Jimi S., Koizumi S., Sato K., Miyazaki M., Saparov A.. Collagen‐Derived Dipeptide Pro‐Hyp Administration Accelerates Muscle Regenerative Healing Accompanied by Less Scarring after Wounding on the Abdominal Wall in Mice. Scientific Reports 11, no. 1 (2021): 18750.
    pmc: PMC8455591pubmed: 34548594
  35. Sato K., Asai T. T., Jimi S.. Collagen‐Derived Di‐Peptide, Prolylhydroxyproline (Pro‐Hyp): A New Low Molecular Weight Growth‐Initiating Factor for Specific Fibroblasts Associated With Wound Healing. Frontiers in Cell and Developmental Biology 8 (2020): 548975.
    pmc: PMC7728856pubmed: 33330443
  36. Ide K., Takahashi S., Sakai K.. The Dipeptide Prolyl‐Hydroxyproline Promotes Cellular Homeostasis and Lamellipodia‐Driven Motility via Active β1‐integrin in Adult Tendon Cells. Journal of Biological Chemistry 297, no. 1 (2021): 100819.
    pmc: PMC8239475pubmed: 34029590
  37. Wu G., Bazer F. W., Burghardt R. C.. Proline and Hydroxyproline Metabolism: Implications for Animal and Human Nutrition. Amiacids 40, no. 4 (2011): 1053–1063.
    pmc: PMC3773366pubmed: 20697752
  38. Pechanec M. Y., Lee‐Barthel A., Baar K., Mienaltowski M. J.. Evaluation and Optimization of a Three‐Dimensional Construct Model for Equine Superficial Digital Flexor Tendon. Journal of Equine Veterinary Science 71 (2018): 90–97.
  39. Ömeroğlu S., Peker T., Türközkan N., Ömeroğlu H.. High‐Dose Vitamin C Supplementation Accelerates the Achilles Tendon Healing in Healthy Rats. Archives of Orthopaedic and Trauma Surgery 129, no. 2 (2009): 281–286.
    pubmed: 18309503
  40. Ramakers C., Ruijter J. M., Deprez R. H. L., Moorman A. F. M.. Assumption‐Free Analysis of Quantitative Real‐Time Polymerase Chain Reaction (PCR) Data. Neuroscience Letters 339, no. 1 (2003): 62–66.
    pubmed: 12618301
  41. Schefe J. H., Lehmann K. E., Buschmann I. R., Unger T., Funke‐Kaiser H.. Quantitative Real‐Time RT‐PCR Data Analysis: Current Concepts and the Novel ‘Gene Expression's CT Difference’ Formula. Journal of Molecular Medicine 84, no. 11 (2006): 901–910.
    pubmed: 16972087
  42. Lee‐Barthel A., Baar K., West W. D. W.. Treatment of Ligament Constructs With Exercise‐Conditioned Serum: A Translational Tissue Engineering Model. Journal of Visualized Experiments: JoVE 11, no. 124 (2017): 55339.
    pmc: PMC5608388pubmed: 28654031
  43. Kesava Reddy G., Enwemeka C. S.. A Simplified Method for the Analysis of Hydroxyproline in Biological Tissues. Clinical Biochemistry 29, no. 3 (1996): 225–229.
    pubmed: 8740508
  44. Schindelin J., Arganda‐Carreras I., Frise E.. Fiji: An Open‐Source Platform for Biological‐Image Analysis. Nature Methods 9, no. 7 (2012): 676–682.
    pmc: PMC3855844pubmed: 22743772
  45. Rezakhaniha R., Agianniotis A., Schrauwen J. T. C.. Experimental Investigation of Collagen Waviness and Orientation in the Arterial Adventitia Using Confocal Laser Scanning Microscopy. Biomechanics and Modeling in Mechanobiology 11, no. 3–4 (2012): 461–473.
    pubmed: 21744269
  46. Weisstein EW. Gaussian Function. .
  47. Freund I, Deutsch M, Sprecher A. Connective Tissue Polarity. Optical Second‐Harmonic Microscopy, Crossed‐Beam Summation, and Small‐Angle Scattering in Rat‐Tail Tendon. Biophysical Journal 50, no. 4 (1986): 693–712.
    pmc: PMC1329848pubmed: 3779007
  48. Zhang G, Ezura Y, Chervoneva I. Decorin Regulates Assembly of Collagen Fibrils and Acquisition of Biomechanical Properties during Tendon Development. Journal of Cellular Biochemistry 98, no. 6 (2006): 1436–1449.
    pubmed: 16518859
  49. Dyment NA, Hagiwara Y, Matthews BG, Li Y, Kalajzic I, Rowe DW. Lineage Tracing of Resident Tendon Progenitor Cells during Growth and Natural Healing. PLoS One 9, no. 4 (2014): e96113.
    pmc: PMC3997569pubmed: 24759953
  50. Nagata K. Expression and Function of Heat Shock Protein 47: A Collagen‐Specific Molecular Chaperone in the Endoplasmic Reticulum. Matrix Biology 16, no. 7 (1998): 379–386.
    pubmed: 9524358
  51. Bukau B, Weissman J, Horwich A. Molecular Chaperones and Protein Quality Control. Cell 125, no. 3 (2006): 443–451.
    pubmed: 16678092
  52. Richter K, Haslbeck M, Buchner J. The Heat Shock Response: Life on the Verge of Death. Molecular Cell 40, no. 2 (2010): 253–266.
    pubmed: 20965420
  53. Harding HP, Zhang Y, Bertolotti A, Zeng H, Ron D. Perk Is Essential for Translational Regulation and Cell Survival During the Unfolded Protein Response. Molecular Cell 5, no. 5 (2000): 897–904.
    pubmed: 10882126
  54. Tabas I, Ron D. Integrating the Mechanisms of Apoptosis Induced by Endoplasmic Reticulum Stress. Nature Cell Biology 13, no. 3 (2011): 184–190.
    pmc: PMC3107571pubmed: 21364565
  55. Mead MP, Gumucio JP, Awan TM, Mendias CL, Mendias CL, Sugg KB. Pathogenesis and Management of Tendinopathies in Sports Medicine. Translational Sports Medicine 1, no. 1 (2018): 5–13.
    pmc: PMC6530902pubmed: 31131372
  56. Ackerman JE, Best KT, Muscat SN, Loiselle AE. Metabolic Regulation of Tendon Inflammation and Healing Following Injury. Current Rheumatology Reports 23, no. 3 (2021): 15.
    pmc: PMC7983167pubmed: 33569739
  57. Subramanian A, Kanzaki LF, Galloway JL, Schilling TF. Mechanical Force Regulates Tendon Extracellular Matrix Organization and Tenocyte Morphogenesis Through TGFbeta Signaling. eLife 7 (2018): e38069.
    pmc: PMC6345564pubmed: 30475205

Citations

This article has been cited 0 times.